{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:13:49Z","timestamp":1792826029445,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Bundesverband Neurofibromatose e.V."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13023-018-0811-9","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T08:02:35Z","timestamp":1524470555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6923-3019","authenticated-orcid":false,"given":"Laura","family":"Sellmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"Farschtschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Marangoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manraj K. S.","family":"Heran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Birch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor-Felix","family":"Mautner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,23]]},"reference":[{"key":"811_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/archderm.141.1.71","volume":"141","author":"M Lammert","year":"2005","unstructured":"Lammert M, Friedman JM, Kluwe L, Mautner V-F. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol. 2005;141:71\u20134.","journal-title":"Arch Dermatol"},{"key":"811_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0896-6273(93)90324-K","volume":"10","author":"DH Gutmann","year":"1993","unstructured":"Gutmann DH, Collins FS. The neurofibromatosis type 1 gene and its protein product, neurofibromin. Neuron. 1993;10:335\u201343.","journal-title":"Neuron"},{"key":"811_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0092-8674(90)90253-B","volume":"62","author":"RM Cawthon","year":"1990","unstructured":"Cawthon RM, Weiss R, Xu GF, Viskochil D, Culver M, Stevens J, Robertson M, Dunn D, Gesteland R, O\u2019Connell P, White R, Bader JL, Miller RW, Birnboim HC, Buchberg AM, Bedigian HG, Jenkins NA, Copeland NG, Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL, Cawthon RM, O\u2019Connell P, Buchberg AM, et al. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell. 1990;62:193\u2013201.","journal-title":"Cell"},{"key":"811_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1126\/science.2134734","volume":"249","author":"MR Wallace","year":"1990","unstructured":"Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science (80- ). 1990;249:181\u20136.","journal-title":"Science (80- )"},{"key":"811_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/GIM.0b013e3181bf15e3","volume":"12","author":"K Jett","year":"2010","unstructured":"Jett K, Friedman JM. Clinical and genetic aspects of neurofibromatosis 1. Genet Med. 2010;12:1\u201311.","journal-title":"Genet Med"},{"key":"811_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/ana.410410204","volume":"41","author":"R Listernick","year":"1997","unstructured":"Listernick R, Louis DN, Packer RJ, Gutmann DH. Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 optic pathway glioma task force. Ann Neurol. 1997;41:143\u20139.","journal-title":"Ann Neurol"},{"key":"811_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/pbc.24726","volume":"61","author":"E Kalin-Hajdu","year":"2014","unstructured":"Kalin-Hajdu E, D\u00e9carie J-C, Marzouki M, Carret A-S, Ospina LH. Visual acuity of children treated with chemotherapy for optic pathway gliomas. Pediatr Blood Cancer. 2014;61:223\u20137.","journal-title":"Pediatr Blood Cancer"},{"key":"811_CR8","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/neuonc\/nos076","volume":"14","author":"MJ Fisher","year":"2012","unstructured":"Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ, Packer RJ, Tabori U, Hoffman RO, Ardern-Holmes SL, Hummel TR, Hargrave DR, Bouffet E, Charrow J, Bilaniuk LT, Balcer LJ, Liu GT. Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro-Oncology. 2012;14:790\u20137.","journal-title":"Neuro-Oncology"},{"key":"811_CR9","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/neuonc\/not068","volume":"15","author":"PMK de Blank","year":"2013","unstructured":"de Blank PMK, Berman JI, Liu GT, Roberts TPL, Fisher MJ. Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1. Neuro-Oncology. 2013;15:1088\u201395.","journal-title":"Neuro-Oncology"},{"key":"811_CR10","unstructured":"National Institutes of Health: National Institutes of Health consensus development conference statement: neurofibromatosis. Bethesda: Neurofibromatosis; July 13\u201315, 1987 Volume 1; 1988. p. 172\u2013178."},{"key":"811_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ejpn.2011.10.002","volume":"16","author":"JRL Ferraz-Filho","year":"2012","unstructured":"Ferraz-Filho JRL, Jos\u00e9 da Rocha A, Muniz MP, Souza AS, Goloni-Bertollo EM, Pavarino-Bertelli EC, Pavarino-Bertelli \u00c9C. Unidentified bright objects in neurofibromatosis type 1: conventional MRI in the follow-up and correlation of microstructural lesions on diffusion tensor images. Eur J Paediatr Neurol. 2012;16:42\u20137.","journal-title":"Eur J Paediatr Neurol"},{"key":"811_CR12","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jpeds.2015.07.001","volume":"167","author":"CE Prada","year":"2015","unstructured":"Prada CE, Hufnagel RB, Hummel TR, Lovell AM, Hopkin RJ, Saal HM, Schorry EK. The use of magnetic resonance imaging screening for optic pathway gliomas in children with Neurofibromatosis type 1. J Pediatr. 2015;167:851\u2013856.e1.","journal-title":"J Pediatr"},{"key":"811_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ejpn.2015.12.002","volume":"20","author":"G Blanchard","year":"2016","unstructured":"Blanchard G, Lafforgue MP, Lion-Fran\u00e7ois L, Kemlin I, Rodriguez D, Castelnau P, Carneiro M, Meyer P, Rivier F, Barbarot S, Chaix Y. Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort. Eur J Paediatr Neurol. 2016;20:275\u201381.","journal-title":"Eur J Paediatr Neurol"},{"key":"811_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/ajmg.a.20650","volume":"127A","author":"MA Blazo","year":"2004","unstructured":"Blazo MA, Lewis RA, Chintagumpala MM, Frazier M, McCluggage C, Plon SE. Outcomes of systematic screening for optic pathway tumors in children with Neurofibromatosis type 1. Am J Med Genet Part A. 2004;127A:224\u20139.","journal-title":"Am J Med Genet Part A"},{"key":"811_CR15","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1136\/bjophthalmol-2015-306958","volume":"100","author":"MH Levin","year":"2016","unstructured":"Levin MH, Armstrong GT, Broad JH, Zimmerman R, Bilaniuk LT, Feygin T, Li Y, Liu GT, Fisher MJ. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening. Br J Ophthalmol. 2016;100:510\u20134.","journal-title":"Br J Ophthalmol"},{"key":"811_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/brain\/122.3.473","volume":"122","author":"A Cr\u00e9ange","year":"1999","unstructured":"Cr\u00e9ange A, Zeller J, Rostaing-Rigattieri S, Brugi\u00e8res P, Degos JD, Revuz J, Wolkenstein P. Neurological complications of neurofibromatosis type 1 in adulthood. Brain. 1999;122:473\u201381.","journal-title":"Brain"},{"key":"811_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jaapos.2009.11.020","volume":"14","author":"L Segal","year":"2010","unstructured":"Segal L, Darvish-Zargar M, Dilenge ME, Ortenberg J, Polomeno RC. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients. J AAPOS. 2010;14:155\u20138.","journal-title":"J AAPOS"},{"key":"811_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/ajmg.a.20211","volume":"122A","author":"A King","year":"2003","unstructured":"King A, Listernick R, Charrow J, Piersall L, Gutmann DH. Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome. Am J Med Genet A. 2003;122A:95\u20139.","journal-title":"Am J Med Genet A"},{"key":"811_CR19","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1007\/s00247-013-2694-1","volume":"43","author":"J Ji","year":"2013","unstructured":"Ji J, Shimony J, Gao F, McKinstry RC, Gutmann DH. Optic nerve tortuosity in children with neurofibromatosis type 1. Pediatr Radiol. 2013;43:1336\u201343.","journal-title":"Pediatr Radiol"},{"key":"811_CR20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/brain\/awg016","volume":"126","author":"J-S Guillamo","year":"2003","unstructured":"Guillamo J-S, Creange A, Kalifa C, Grill J, Rodriguez D, Doz F, Barbarot S, Zerah M, Sanson M, Bastuji-Garin S, Wolkenstein P. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients. Brain. 2003;126:152\u201360.","journal-title":"Brain"},{"key":"811_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1055\/s-2007-973687","volume":"28","author":"JM Friedman","year":"1997","unstructured":"Friedman JM, Birch P. An association between optic glioma and other tumours of the central nervous system in neurofibromatosis type 1. Neuropediatrics. 1997;28:131\u20132.","journal-title":"Neuropediatrics"},{"key":"811_CR22","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1007\/s00381-006-0061-3","volume":"22","author":"M Piccirilli","year":"2006","unstructured":"Piccirilli M, Lenzi J, Delfinis C, Trasimeni G, Salvati M, Raco A. Spontaneous regression of optic pathways gliomas in three patients with neurofibromatosis type I and critical review of the literature. Childs Nerv Syst. 2006;22:1332\u20137.","journal-title":"Childs Nerv Syst"},{"issue":"3 Pt 1","key":"811_CR23","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1212\/WNL.42.3.679","volume":"42","author":"AE Brzowski","year":"1992","unstructured":"Brzowski AE, Bazan C, Mumma JV, Ryan SG. Spontaneous regression of optic glioma in a patient with neurofibromatosis. Neurology. 1992;42(3 Pt 1):679\u201381.","journal-title":"Neurology"},{"key":"811_CR24","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/archopht.119.4.516","volume":"119","author":"CF Parsa","year":"2001","unstructured":"Parsa CF, Hoyt CS, Lesser RL, Weinstein JM, Strother CM, Muci-Mendoza R, Ramella M, Manor RS, Fletcher WA, Repka MX, Garrity JA, Ebner RN, Monteiro ML, McFadzean RM, Rubtsova IV, Hoyt WF. Spontaneous regression of optic gliomas: thirteen cases documented by serial neuroimaging. Arch Ophthalmol. 2001;119:516\u201329.","journal-title":"Arch Ophthalmol"},{"key":"811_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ana.24093","volume":"75","author":"KA Diggs-Andrews","year":"2014","unstructured":"Diggs-Andrews KA, Brown JA, Gianino SM, Rubin JB, Wozniak DF, Gutmann DH. Sex is a major determinant of neuronal dysfunction in neurofibromatosis type 1. Ann Neurol. 2014;75:309\u201316.","journal-title":"Ann Neurol"},{"key":"811_CR26","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1148\/radiology.195.3.7754001","volume":"195","author":"DP DiPaolo","year":"1995","unstructured":"DiPaolo DP, Zimmerman RA, Rorke LB, Zackai EH, Bilaniuk LT, Yachnis AT. Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain. Radiology. 1995;195:721\u20134.","journal-title":"Radiology"},{"key":"811_CR27","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.nicl.2014.04.005","volume":"4","author":"T Billiet","year":"2014","unstructured":"Billiet T, M\u00e4dler B, D\u2019Arco F, Peeters R, Deprez S, Plasschaert E, Leemans A, Zhang H, den Bergh BV, Vandenbulcke M, Legius E, Sunaert S, Emsell L. Characterizing the microstructural basis of \u201cunidentified bright objects\u201d in neurofibromatosis type 1: a combined in vivo multicomponent T2 relaxation and multi-shell diffusion MRI analysis. NeuroImage Clin. 2014;4:649\u201358.","journal-title":"NeuroImage Clin"},{"issue":"6","key":"811_CR28","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/glia.22945","volume":"64","author":"SJ Baker","year":"2016","unstructured":"Baker SJ, Ellison DW, Gutmann DH. Pediatric gliomas as neurodevelopmental disorders. Glia. 2016;64(6):879\u201395.","journal-title":"Glia"},{"key":"811_CR29","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1212\/WNL.59.5.759","volume":"59","author":"DH Gutmann","year":"2002","unstructured":"Gutmann DH, Rasmussen SA, Wolkenstein P, MacCollin MM, Guha A, Inskip PD, North KN, Poyhonen M, Birch PH, Friedman JM. Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1). Neurology. 2002;59:759\u201361.","journal-title":"Neurology"},{"key":"811_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13023-017-0588-2","volume":"12","author":"L Sellmer","year":"2017","unstructured":"Sellmer L, Farschtschi S, Marangoni M, Heran MKS, Birch P, Wenzel R, Friedman JM, Mautner V-F. Non-optic glioma in adults and children with neurofibromatosis 1. Orphanet J Rare Dis. 2017;12:34.","journal-title":"Orphanet J Rare Dis"},{"key":"811_CR31","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11060-017-2517-6","volume":"134","author":"E Trevisson","year":"2017","unstructured":"Trevisson E, Cassina M, Opocher E, Vicenzi V, Lucchetta M, Parrozzani R, Miglionico G, Mardari R, Viscardi E, Midena E, Clementi M. Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1. J Neuro-Oncol. 2017;134:279\u201387.","journal-title":"J Neuro-Oncol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0811-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-018-0811-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0811-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T02:53:22Z","timestamp":1720234402000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0811-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,23]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["811"],"URL":"https:\/\/doi.org\/10.1186\/s13023-018-0811-9","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,23]]},"assertion":[{"value":"5 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ethical committees of the Medical Chamber in Hamburg and the Research Ethics Board of the University of British Columbia approved the study. Written consent was obtained from all study participants before study begin. All data were de-identified before analysis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"62"}}